Effectiveness of a Nutritional Supplement With Anti‐Inflammatory Compounds and Olive Oil in Malnourished Patients
Journal of Cachexia, Sarcopenia and Muscle · 2026-12 · 17 (6)
DOI: 10.1002/jcsm.70417 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 15.11.2026. Verfasst von Alfonso Vidal-Casariego und 13 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Endocrinología y Nutrición, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain. Hauptthemen laut MEDLINE: Dietary Supplements, Olive Oil, Anti-Inflammatory Agents, Malnutrition. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NutriMed Clinical Nutrition S.L., Spain.
Abstract (Originalsprache)
Background
Disease‐related malnutrition (DRM) with systemic inflammation is associated with poor clinical outcomes and muscle mass loss. This study in a real‐world clinical practice examined whether an oral nutritional supplement (ONS) enriched with anti‐inflammatory compounds—eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and extra‐virgin olive oil (EVOO)—was associated with improvements in nutritional status, muscle mass and functional performance in patients with inflammation‐related DRM.
Methods
In this 12‐week prospective multicenter cohort study, adults diagnosed with DRM and elevated C‐reactive protein (CRP > 3 mg/L) received either an anti‐inflammatory ONS or standard ONS, both combined with dietary counselling and a structured physical activity programme. Outcomes included anthropometry, body composition (bioimpedance and ultrasound), muscle function, inflammatory markers and quality of life.
Results
Of 266 participants (mean age 66.6 ± 12.9 years; 61.7% male), those receiving the anti‐inflammatory ONS ( n = 165) achieved significantly greater increases in fat‐free mass (Δ +1.20 vs. −0.85 kg; p = 0.022), skeletal muscle index (Δ +0.12 vs. −0.21 kg/m 2 ; p = 0.022) and rectus femoris circumference by ultrasound (Δ +0.43 vs. −0.13 cm; p = 0.042) compared with controls ( n = 101). Functional improvements were also superior: Chair stand repetitions increased significantly (Δ +0.90 vs. +0.03 times; p = 0.025), with a trend toward reduced Timed Up and Go time. Quality of life improved significantly across physical and mental domains in the anti‐inflammatory group (e.g., VAS: Δ +11.1 vs. −10.8; p < 0.001). After adjustment for baseline values, age, sex, GLIM severity, CRP and primary diagnosis, differences remained significant for SMI (0.10 kg/m 2 ; 95% CI, 0.01–0.19), fat‐free mass, muscle circumference, chair stand and EQ VAS (12.85 points; 95% CI, 5.61–20.08), but not for handgrip strength. Twelve‐week mortality was higher with the anti‐inflammatory ONS (11.5% vs. 4.95%; adjusted OR, 3.35; 95% CI, 1.06–13.81).
Conclusions
In this post hoc analysis, the use of an ONS enriched with EPA, DHA and EVOO, combined with physical activity and dietary counselling, was associated with greater gains in muscle mass, lower‐limb strength and quality of life in patients with inflammation‐associated DRM, but also with higher short‐term mortality. Because residual confounding cannot be excluded, these findings are hypothesis‐generating; randomized controlled trials with prespecified safety outcomes are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Endocrinología y Nutrición, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain.
- Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid and Health Research Institute of Valladolid (IBioVALL. Centro de Investigación de Endocrinología y Nutrición Fac Medicina Universidad…
- Servicio de Endocrinología y Nutrición, Hospital Virgen de la Victoria, Málaga, Spain.
- Servicio de Endocrinología y Nutrición, Hospital Universitario Virgen de las Nieves, Granada, Spain.
- Servicio de Endocrinología y Nutrición, Complexo Hospitalario Universitario de Ferrol, Ferrol, Spain.
- Servicio de Endocrinología y Nutrición, Hospital Universitario La Paz, Madrid, Spain.
ORCID-Profile: Alfonso Vidal-Casariego, Juan José López Gómez, Juan Manuel Guardia Baena, Samara Palma Milla, Agustín Ramos Prol, Natalia C Iglesias Hernández, Luis M Luengo Pérez, Daniel de Luis Román
Förderung
- NutriMed Clinical Nutrition S.L., Spain
Zitieren
APA
Vidal-Casariego, A., Gómez, J. J. L., Almeida, J. M. G., Aguilar, I. V., Baena, J. M. G., Pérez, C. T., Milla, S. P., Ricciardi, P. M., Prol, A. R., Luna, P. P. G., Gil, B. M., Iglesias Hernández, N. C., Luengo Pérez, L. M., & de Luis Román, D. (2026). Effectiveness of a Nutritional Supplement With Anti‐Inflammatory Compounds and Olive Oil in Malnourished Patients. Journal of Cachexia, Sarcopenia and Muscle, 17(6). https://doi.org/10.1002/jcsm.70417
Vancouver
Vidal-Casariego A, Gómez JJL, Almeida JMG, Aguilar IV, Baena JMG, Pérez CT, et al. Effectiveness of a Nutritional Supplement With Anti‐Inflammatory Compounds and Olive Oil in Malnourished Patients. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(6). doi:10.1002/jcsm.70417
BibTeX
@article{VidalCasariego2026,
author = {Vidal-Casariego, Alfonso and Gómez, Juan José López and Almeida, José Manuel García and Aguilar, Isabel Vegas and Baena, Juan Manuel Guardia and Pérez, Cristina Tejera and Milla, Samara Palma and Ricciardi, Patricia Mezerhane and Prol, Agustín Ramos and Luna, Pedro Pablo García and Gil, Beatriz Mantiñán and Iglesias Hernández, Natalia C and Luengo Pérez, Luis M and de Luis Román, Daniel},
title = {Effectiveness of a Nutritional Supplement With Anti‐Inflammatory Compounds and Olive Oil in Malnourished Patients},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2026},
volume = {17},
number = {6},
doi = {10.1002/jcsm.70417}
}
EUVIMED